Email this article 
Experience using recombinant interferon-alpha with taurine therapy of congenital cytomegalovirus infection in children
- Authors: Chernova T.M1, Baracina E.V2, Zarkua R.Z3
-
Affiliations:
- St Petersburg State Pediatric Medical University Ministry of Health of the Russian Federation
- St Petersburg State Budgetary Healthcare Institution Children’s outpatient department No 34
- St Petersburg State Budgetary Healthcare Institution Children’s outpatient department No 41
- Issue: Vol 7, No 2 (2016)
- Pages: 158-163
- Section: Articles
- URL: https://journals.eco-vector.com/pediatr/article/view/3637
- DOI: https://doi.org/10.17816/PED72158-163
- ID: 3637
Cite item
Open Access
Access granted
Abstract
Cytomegalovirus (CMV) belongs to the most frequent causes of intrauterine infection and can cause birth defects and severe manifestations of the disease fatal. In most cases the infection is latent, but there is a high risk of developing late manifestations. For the prevention of vertical transmission of CMV infection are needed early prenatal diagnosis of infection in a pregnant woman with the definition of the extent of its activity and conduct of antiviral therapy. When intravenous anti-CMV immunoglobulin observed rapid clinical efficacy. However, the titer of circulating antibodies in the child’s body is rapidly reduced, determines the duration of the protective effect of the drug to 4-5 weeks. Since the suppository form of interferon-α with taurine has been used successfully in obstetric practice, we have examined its effectiveness in the treatment of 11 outpatient children aged 1 month to 3 years with congenital CMV infection, 3 of them received specific immunoglobulin baby immediately after birth. The drug was administered rectally by prolonged scheme for 3 months 2 times a day every 12 hours within 10 days, followed by 1 suppository 2 times a day every other day (3 times a week). The therapy in all children experienced rapid resolution of symptoms CMV: normalization of the size of lymph nodes, liver and spleen, blood count, serum ALT, urinalysis, as well as the disappearance of CMV DNA in blood and IgM antibodies to CMV infection after treatment. During 12 months of follow-up episodes of reactivation of CMV infection in any of the observed child is not mentioned.
Keywords
Full Text
About the authors
Tatyana M Chernova
St Petersburg State Pediatric Medical University Ministry of Health of the Russian Federation
Email: t-chernova@mail.ru
MD, PhD, Associate Professor, Department of Infectious Diseases in Children named after Professor M.G. Danilevich
Elena V Baracina
St Petersburg State Budgetary Healthcare Institution Children’s outpatient department No 34
Email: elenabarakina@mail.ru
MD, PhD.
Rusudan Z Zarkua
St Petersburg State Budgetary Healthcare Institution Children’s outpatient department No 41
Email: t-chernova@mail.ru
References
- Артемчик Т.А. Cлучай врожденной цитомегаловирусной инфекции: клиническая картина, трудности диагностики, патоморфологические изменения // Медицинский журнал. - 2012. - Т. 3. - С. 151-152. [Artemchik TA. Cluchay vrozhdennoy tsitomegalovirusnoy infektsii: klinicheskaya kartina, trudnosti diagnostiki, patomorfologicheskie izmeneniya. Meditsinskiy zhurnal. 2012;3:151-152. (In Russ).]
- Инструкция к препарату неоцитотект. Доступен по: http://www.rlsnet.ru/tn_index_id_35536.htm (дата обращения 23.11.2015). [Instruktsiya k preparatu Neotsitotekt. (In Russ).]. Доступен по: http://www.rlsnet.ru/tn_index_id_35536.htm (дата обращения 23.11.2015).
- Керимова Ж.Н. Клиническая структура манифестных форм цитомегаловирусной инфекции у детей раннего возраста и эффективность противовирусной терапии: Автореф. дис. … канд. мед. наук. - Саратов, 2009. [Kerimova ZhN. Klinicheskaya struktura manifestnykh form tsitomegalovirusnoy infektsii u detey rannego vozrasta i effektivnost’ protivovirusnoy terapii. [dissertation]. Saratov; 2009. (In Russ).]
- Клинические рекомендации (протокол лечения) оказания медицинской помощи детям, больным цитомегаловирусной инфекцией. 2015 [Klinicheskie rekomendatsii (protokol lecheniya) okazaniya meditsinskoy pomoshchi detyam bol’nym tsitomegalovirusnoy infektsiey. 2015. (In Russ).]. Доступен по: http://niidi.ru/dotAsset/e16b678a-c3fc-4af2-ba33-0ea0a14e5d24.pdf (дата обращения 23.11.2015).
- Кудашов Н.И. Цитомегаловирусная инфекция у новорожденных: диагностика и лечение // Лечащий врач. Педиатрия. - 2006. - Т. 3. [Kudashov NI. Tsitomegalovirusnaya infektsiya u novorozhdennykh: diagnostika i lechenie. Lechashchiy vrach. Pediatriya. 2006:3. (In Russ).] Доступен по: http://new.lvrach.ru/2006/03/4533630/ (дата обращения 20.11.2015).
- Кузьмин В.Н. Диагностика, лечение и профилактика цитомегаловирусной инфекции у беременных // Лечащий врач. - 2002. - Т. 11. [Kuz’min VN. Diagnostika, lechenie i profilaktika tsitomegalovirusnoy infektsii u beremennykh. Lechashchiy vrach. 2002:11. (In Russ).]. Доступен по: http://www.lvrach.ru/2002/11/4529792/ (дата обращения 20.11.2015).
- Мангушева Я.Р., Хаертынова И.М., Мальцева Л.И. Цитомегаловирусная инфекция у детей // Практическая медицина. - 2014. - Т. 7. - С. 11-16. [Mangusheva YaR, Khaertynova IM, Mal’tseva LI. Tsitomegalovirusnaya infektsiya u detey. Prakticheskaya meditsina. 2014;7:11-16. (In Russ).]
- Маринкин И.О., Трунов А.Н., Карпович Л.А. Эффективность препарата Генферон® лайт в комплексной терапии беременных высокого инфекционного риска // Актуальность применения препаратов интерферона альфа-2β в терапии урогенитального тракта: пособие для врачей. - СПб.: BIOCAD Biopharmaceutical Company, 2014. - С. 45-56. [Marinkin IO, Trunov AN, Karpovich LA. Effektivnost’ preparata Genferon® layt v kompleksnoy terapii beremennykh vysokogo infektsionnogo riska. In: Aktual’nost’ primeneniya preparatov interferona al’fa-2β v terapii urogenital’nogo trakta: posobie dlya vrachey. Saint Petersburg: BIOCAD Biopharmaceutical Company; 2014:45-56. (In Russ).]
- Цитомегаловирусная инфекция. Перинатальные инфекции (А.Я. Сенчук, З.М. Дубоссарская, ред.). - М.: МИА, 2005:106-127. [Tsitomegalovirusnaya infektsiya. In: Perinatal’nye infektsii. Ed by AYa Senchuk, ZM Dubossarskaya. Moscow: MIA; 2005:106-127. (In Russ).]
- Яцык Г.В., Одинаева Н.Д., Беляева И.А. Цитомегаловирусная инфекция // Практика педиатра. - 2009. - Октябрь. - С. 5-12. [Yatsyk GV, Odinaeva ND, Belyaeva IA. Tsitomegalovirusnaya infektsiya. Praktika pediatra. 2009;October:5-12. (In Russ).]
- Cytomegalovirus (CMV) and Congenital CMV Infection. Centers for disease control fnd prevention. Available at: http://www.cdc.gov/cmv/congenital-infection.html (accessed 20.11.2015).
- Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr. 2003;143(1):16-25. doi: 10.1016/S0022-3476(03)00192-6.
- Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus infection. Rev Med Virol. 2007;17:253-276. doi: 10.1002/rmv.535.
- Nassetta L, Kimberlin D, Whitley R. Treatment of congenital cytomegalovirus infection: implications for future therapeutic strategies. J Antimicrobial Chemotherapy. 2009;63:862-867. doi: 10.1093/jac/dkp083.
- Saetta A, Agapitos E, Davaris PS. Determination of CMV placentitis (Diagnostic application of the polymerase chain reaction). Virchows Arch. 1998;432:159-162. doi: 10.1007/s004280050150.
- Torigoe S, Campbell DE, Starr SE. Cytokines released by human peripheral blood mononuclear cells inhibit the production of early and late cytomegalovirus proteins. Microbiol Immunol. 1997;41:403-413. doi: 10.1111/j.1348-0421.1997.tb01871.x.
- Weiss SJ, Klein R, Slivka A, Wei M. Chlorination of taurine by human neutrophils. Evidence for hypochlorous acid generation. J Clin Inves. 1982;70 (3):598-607. doi: 10.1172/JCI110652.
Supplementary files
